patient presents with recurrent prostate cancer. Cryoablation therapy is planned. Initially, ultrasound (US) was used to assess the prostate cancer recurrence and needle path course. A transperineal grid was placed against the perineum, and magnetic resonance imaging (MRI) was used to image and guide needles through the grid into the prostate for ablation. CPT code 55873 describes ablation including US guidance. Code 77022 (MRI imaging guidance for parenchymal tissue ablation) describes MRI imaging guidance for parenchymal tissue ablation. CCI edits disallow reporting of these two codes together at the same encounter. If the needles/catheters are not inserted using real-time US guidance (but through the grid placed by US imaging), is it appropriate to report code 55873 ? ...

Subscribe or sign in to view the full article.

Sign In Subscribe Today

Note:  The following article synopsis was NOT provided by the AMA. It was created by Find-A-Code/innoviHealth.

Article Overview

This article explains a prostate cancer cryoablation scenario involving imaging guidance and code selection considerations. It is aimed at coding and reimbursement professionals who need to understand how CPT guidance, modifier usage, and claim-edit issues may apply when multiple imaging modalities are involved. The discussion also notes that payer policy may differ from CPT guidance and that coverage determinations are made by individual insurers.

Why This Topic Matters

Accurate reporting of imaging-guided ablation services can affect claim acceptance, payment, and compliance with payer-specific policies. The article highlights a situation where guidance modality, modifier use, and edit rules can influence how the service is reported.

Codes Discussed

• CPT: 55873
• CPT: 77022

Modifiers Discussed

• CPT: 52

Subscribe or sign in to view the full article.

Sign In Subscribe Today